A 54-year-old software developer with no prior psychiatric history is evaluated for Major Depressive Disorder (MDD). Arrange the following pharmacological and somatic management steps in the correct chronological sequence according to standard stepped-care escalation protocols, starting from the initial presentation to the eventual management of a severe, life-threatening refractory state.
- 1Initiate monotherapy with a selective serotonin reuptake inhibitor (SSRI).
- 2Switch to a different antidepressant class (e.g., an SNRI) after an adequate trial yields zero clinical improvement.
- 3Augment the current regimen with an atypical antipsychotic following a partial response to the second antidepressant.
- 4Administer electroconvulsive therapy (ECT) upon the development of treatment-resistant depression complicated by acute food refusal.
Cevap
The correct sequence of treatment escalation for MDD is: 1) Initiate SSRI monotherapy, 2) Switch to an SNRI for non-response, 3) Augment with an atypical antipsychotic for partial response, and 4) Administer ECT for life-threatening treatment-resistant depression.
The correct stepped-care escalation for major depressive disorder begins with SSRI monotherapy. If there is no response, switching to a different antidepressant (like an SNRI) is indicated. If there is a subsequent partial response, augmentation (e.g., with an atypical antipsychotic) is preferred to maximize the partial gains. Finally, if the patient becomes completely treatment-resistant and develops life-threatening complications like food refusal, ECT is the definitive, rapid-acting treatment of choice.
Adım Adım Çözüm
Anahtar Kavram
The stepped-care approach to Major Depressive Disorder involves initiating first-line monotherapy, switching agents for complete non-response, augmenting for partial response, and utilizing somatic therapies like ECT for severe, treatment-resistant, or life-threatening disease.